![](/img/cover-not-exists.png)
A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC® , administered simultaneously with or without the buffering agent in healthy infants in India
Ella, Raches, Bobba, Radhika, Muralidhar, Sanjay, Babji, Sudhir, Vadrevu, Krishna Mohan, Bhan, Maharaj KishanLanguage:
english
Journal:
Human Vaccines & Immunotherapeutics
DOI:
10.1080/21645515.2018.1450709
Date:
March, 2018
File:
PDF, 1.32 MB
english, 2018